SGLT2 Inhibition in Older Obese Adults With Pre-diabetes (SGLT2i)
Effect of SGLT2 Inhibition on Aging-related Biomarkers in Older Obese Adults With Pre-diabetes
Sponsor: National Institute on Aging (NIA)
A PHASE1/PHASE2 clinical study on Aging, this trial is completed. The trial is conducted by National Institute on Aging (NIA) and has accumulated 10 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Feb 2024 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
Status: Active Not Recruiting → Completed
-
Aug 2023 — Feb 2024 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Feb 2023 — Aug 2023 [monthly]
Active Not Recruiting PHASE1_PHASE2
Status: Recruiting → Active Not Recruiting
▶ Show 5 earlier versions
-
Jan 2022 — Feb 2023 [monthly]
Recruiting PHASE1_PHASE2
-
Mar 2021 — Jan 2022 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2021 — Mar 2021 [monthly]
Recruiting PHASE1_PHASE2
-
Aug 2020 — Jan 2021 [monthly]
Recruiting PHASE1_PHASE2
Status: Not Yet Recruiting → Recruiting
-
Jun 2020 — Aug 2020 [monthly]
Not Yet Recruiting PHASE1_PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute on Aging (NIA)
- The University of Texas Health Science Center at San Antonio
For direct contact, visit the study record on ClinicalTrials.gov .